Good Tolerance of Citrate Accumulation due to Plasma Exchange among Patients with Acute-on-Chronic Liver Failure: A Prospective, Observational Study

Table 1

Baseline laboratory parameters of patients before the first session of ALSS therapy.

Hemoglobin, g/dL	11.1 ± 2.1
Platelets, ×10^9/L	126 ± 76
White blood cells, ×10^9/L	8.2 ± 6.5
INR	2.0 ± 0.6
Total bilirubin, μmol/L	408.1 ± 137.1
Direct bilirubin, μmol/L	307.2 ± 107.9
Alanine transaminase, IU/L	200 ± 232
Aspartate transaminase, IU/L	177 ± 178
Alkaline phosphatase, IU/L	223 ± 320
gamma-Glutamyl transferase, IU/L	141 ± 276
Albumin, g/L	32.1 ± 4.4
Globulin, g/L	28.2 ± 8.2
Total bile acid, μmol/L	290.7 ± 78.6
Creatinine, μmol/L	101 ± 91
Ammonia, mmol/L	76 ± 35
Sodium, mmol/L	133.9 ± 5.3
Potassium, mmol/L	3.4 ± 0.6
Chloride, mmol/L	97.1 ± 6.4
MELD scores	25 ± 7

ALSS, artificial liver support system; MELD, model for end-stage liver disease; INR, international normalized ratio; measurement data are represented as mean ± SD.